Diabetic Retinopathy is the leading cause of blindness in working age adults, but it can be prevented through early detection. Unfortunately, many people miss routine eye exams and that led Hill-Rom’s Welch Allyn to develop RetinaVue.

RetinaVue is a handheld imager used detect diabetic retinopathy right in a primary care setting, enabling doctors to incorporate vision exams during regular patient visits. Dr. Paul Fiacco, a founding physician at CNY Family Care, notes how many people this device could impact by reviewing some of the numbers. Approximately 29 million Americans have diabetes, 1.7 million are developing it and roughly  80% will develop retinopathy. There’s little to do once blind so prevention is key. The condition is caused by damage to the blood vessels at the back of the retina due to high blood pressure. Symptoms as subtle as mild vision impairments can often be seen as a parallel to growing old and therefore not as concerning.

A demonstration of the exam shows how simple and painless it really is. It only takes a few seconds and can save a person’s vision. 95% of vision loss can be prevented but as Chuck Witkowski, Vice President of Vision Care at Welch Allyn says, “the challenge is really getting them to get that annual eye exam, less than 50% actually go… RetinaVue makes this exam simple and affordable for the primary care setting.” Therefore, when a diabetic goes to their doctor for regular blood work, they can get this quick check.

For more information about RetinaVue, visit retinavue.com.